Karl Martin Klein

Country flagGermany

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Objective The phenotypic and genotypic spectrum of adult patients with epilepsy and intellectual disability (ID) is less clear than in children. We investigated an adult patient cohort to further elucidate this and inform the genetic testing approach. Methods Fifty‐two adult patients (30 male, 22 female) with epilepsy, at least mild ID and no known genetic or acquired cause were included and phenotyped. Variants identified through exome sequencing were evaluated using ACMG criteria. Identified variants were compared with commercially available gene panels. Cluster analysis of two features, age at seizure onset and age at ascertainment of cognitive deficits, was performed. Results Median age was 27 years (range 20‐57 years) with median seizure onset at 3 years and median ascertainment of cognitive deficits at 1 year. Likely pathogenic/pathogenic variants were identified in 16/52 patients (31%) including 14 (27%) single nucleotide variants and 2 (4%) copy number variants. Simulated yield of commercial gene panels varied between 13% in small (≤144 genes) and 27% in large panels (≥1478 genes). Cluster analysis (optimal number 3 clusters) identified a cluster with early seizure onset and early developmental delay (developmental and epileptic encephalopathy, n = 26), a cluster with early developmental delay but late seizure onset (ID with epilepsy, n = 16) and a third cluster with late ascertainment of cognitive deficits and variable seizure onset (n = 7). The smaller gene panels particularly missed the genes identified in the cluster with early ascertainment of cognitive deficits and later onset of epilepsy (0/4) as opposed to the cluster with developmental and epileptic encephalopathy (7/10). Significance Our data indicates that adult patients with epilepsy and ID represent a heterogeneous cohort that includes grown‐up patients with DEE but also patients with primary ID and later onset of epilepsy. To maximize diagnostic yield in this cohort either large gene panels or exome sequencing should be used.

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (14)

Johann Philipp Zöllner

Goethe University Frankfurt

GERMANY
View details

Gianpiero Cavalleri

Professor of Human Genetics

-

IRELAND
View details

Martin Krenn

Medical University of Vienna

AUSTRIA
View details

Susanne Schubert‐Bast

-

GERMANY
View details

Andreas G Chiocchetti

Prof

Goethe University Frankfurt

GERMANY
View details

Amélie Piton

associate professor

University of Strasbourg

FRANCE
View details

Stefan Wolking

-

GERMANY
View details

Jozef Gecz

-

AUSTRALIA
View details

Maja Tarailo-Graovac

Associate Professor

University of Calgary

CANADA
View details

Francesco Brancati

Professor

University of L'Aquila

ITALY
View details

Astrid Bertsche

-

GERMANY
View details

Juan Pablo Appendino

Clinical Associate Professor

University of Calgary

CANADA
View details

Christel Depienne

Universitätsklinikum Essen Institut für Humangenetik

GERMANY
View details

Tolulope Sajobi

Associate Professor

University of Calgary

CANADA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.